Wikidata entity: Q66037404
Quantities
| P2899 | minimum age | 18 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q16 (Canada) | Canada |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2007-11-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P4844 | research intervention | ... | Q238512 (fluorouracil) | fluorouracil |
| P4844 | research intervention | ... | Q412415 (cisplatin) | cisplatin |
| P6153 | research site | ... | Q1150105 (University of Tennessee) | University of Tennessee |
| P6153 | research site | ... | Q230492 (University of Michigan) | University of Michigan |
| P6153 | research site | ... | Q4858714 (Barbara Ann Karmanos Cancer Institute) | Barbara Ann Karmanos Cancer Institute |
| P6153 | research site | ... | Q7895818 (University of Mississippi Medical Center) | University of Mississippi Medical Center |
| P6153 | research site | ... | Q30256063 (Harrington Cancer Center) | Harrington Cancer Center |
| P6153 | research site | ... | Q30269547 (Michigan Cancer Research Consortium) | Michigan Cancer Research Consortium |
| P6153 | research site | ... | Q56582915 (University of Utah Health Care) | University of Utah Health Care |
| P580 | start time | ... | 2003-04-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Docetaxel (NSC-628503), Cisplatin (NSC-119875), And 5-Fluorouracil (NSC-19893) Induction Chemotherapy Followed By Accelerated Fractionation/Concomitant Boost Radiation And Concurrent Single Agent Cisplatin (NSC-119875), In Patients With Advanced Squamous Cell Head And Neck Cancer | ??? |
| P3098 | ClinicalTrials.gov ID | NCT00054054 |
Why not click here or view trends?
log id: 4855400